Inhibition of MMP13 is an effective strategy to decelerate both ECM loss and osteoarthritis progression.[28] Taken together, HP‐sEVs inhibit the inflammatory environment induced by TNF‐α and possess anti‐inflammatory roles in vitro. The gene discussed is MMP13; the disease is osteoarthritis.